| Did India's price control policy for coronary stents create unintended consequences? S Deo, H Tyagi, C Chatterjee, H Molakapuri Social Science & Medicine 246, 112737, 2020 | 10 | 2020 |
| Leveraging providers’ preferences to customize instructional content in information and communications technology–based training interventions: Retrospective analysis of a … H Tyagi, M Sabharwal, N Dixit, A Pal, S Deo JMIR mHealth and uHealth 8 (3), e15998, 2020 | 7 | 2020 |
| Digitising Indian healthcare records AC Powell, H Tyagi, JK Ludher Healthcare cover story, ISBInsight, 2018 | 3 | 2018 |
| How does Transparency Impact Technological Novelty? Evidence from Large Pharmaceutical Firms H Tyagi, M Hermosilla, R Shah Academy of Management Proceedings 2023 (1), 13909, 2023 | | 2023 |
| EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share V Heitlage, JF Farley, R Shah, H Tyagi, D Stenehjem Value in Health 25 (7), S460, 2022 | | 2022 |
| Does regulatory approval speed impact product quality? Evidence from the US pharmaceutical industry (WITHDRAWN) H Tyagi, R Shah Academy of Management Proceedings 2021 (1), 13426, 2021 | | 2021 |
Sarang DeoProfessor | Operations Management | Indian School of BusinessVerified email at isb.edu
